DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

貢獻的翻譯標題: 去整合蛋白變異體及其醫藥用途

Woei-Jer Chuang (Inventor)

研究成果: Patent

摘要

Disintegrin variants and pharmaceutical uses thereof are disclosed. The disintegrin variant includes an isolated polypeptide that has integrin .alpha.v.beta.3 receptor-antagonist activity and substantially reduced integrin .alpha.llb.beta.3 and/or .alpha.5.beta.1 receptor-blocking activity as compared to a wild-type disintegrin.
原文English
專利號EP 2124548
出版狀態Published - 2009 十二月 2

指紋

Disintegrins
Integrins
Pharmaceutical Preparations
Peptides

引用此文

@misc{f241af05abbd4b8e829845fbf47cb036,
title = "DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF",
abstract = "Disintegrin variants and pharmaceutical uses thereof are disclosed. The disintegrin variant includes an isolated polypeptide that has integrin .alpha.v.beta.3 receptor-antagonist activity and substantially reduced integrin .alpha.llb.beta.3 and/or .alpha.5.beta.1 receptor-blocking activity as compared to a wild-type disintegrin.",
author = "Woei-Jer Chuang",
year = "2009",
month = "12",
day = "2",
language = "English",
type = "Patent",
note = "EP 2124548",

}

TY - PAT

T1 - DISINTEGRIN VARIANTS AND PHARMACEUTICAL USES THEREOF

AU - Chuang, Woei-Jer

PY - 2009/12/2

Y1 - 2009/12/2

N2 - Disintegrin variants and pharmaceutical uses thereof are disclosed. The disintegrin variant includes an isolated polypeptide that has integrin .alpha.v.beta.3 receptor-antagonist activity and substantially reduced integrin .alpha.llb.beta.3 and/or .alpha.5.beta.1 receptor-blocking activity as compared to a wild-type disintegrin.

AB - Disintegrin variants and pharmaceutical uses thereof are disclosed. The disintegrin variant includes an isolated polypeptide that has integrin .alpha.v.beta.3 receptor-antagonist activity and substantially reduced integrin .alpha.llb.beta.3 and/or .alpha.5.beta.1 receptor-blocking activity as compared to a wild-type disintegrin.

M3 - Patent

M1 - EP 2124548

ER -